Citation Impact
Citing Papers
International consensus guidance for management of myasthenia gravis
2016 Standout
Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigen
2009 Standout
Mechanism of action of voltage‐gated K+ channel antibodies in acquired neuromyotonia
2004
Defective recycling of synaptic vesicles in synaptotagmin mutants of Caenorhabditis elegans
1995 StandoutNatureNobel
Molecular machinery mediating vesicle budding, docking and fusion
1996 StandoutNobel
Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies
2001 Standout
Lifetime course of myasthenia gravis
2007 Standout
Myasthenia Gravis
2016 Standout
Multiple paraneoplastic syndromes in a patient with antibodies to neuronal nucleoproteins (anti-Hu)
1995
Cytokines and the pathogenesis of myasthenia gravis
1997
The Lambert-Eaton Myasthenic Syndrome
2001
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Voltage gated calcium channel antibody-related neurological diseases
2015
Therapeutic apheresis in neurological disorders
2000
Difference in distribution of muscle weakness between myasthenia gravis and the Lambert-Eaton myasthenic syndrome
2002
Guillain-Barré syndrome
2016 Standout
Recommended diagnostic criteria for paraneoplastic neurological syndromes
2004 Standout
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
2008 Standout
Cancer immunotherapy via dendritic cells
2012 Standout
Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studies
2010
Passive transfer of seronegative myasthenia gravis to mice
1994
Associated autoimmune diseases in patients with the Lambert-Eaton myasthenic syndrome and their families
2004
IgG1 antibodies to acetylcholine receptors in ‘seronegative’ myasthenia gravis†
2008
Lambert–Eaton myasthenic syndrome (LEMS): a rare autoimmune presynaptic disorder often associated with cancer
2017
Synaptic Pathophysiology and Treatment of Lambert-Eaton Myasthenic Syndrome
2014
Lambert-Eaton Myasthenic Syndrome
2004
Myasthenia Gravis
1994 Standout
Pre‐ and postsynaptic blockade of neuromuscular transmission by Miller–Fisher syndrome IgG at mouse motor nerve terminals
1998
Paraneoplastic Neurologic Syndromes: Pathogenesis and Physiopathology
1999
Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity
2009 Standout
A systematic review of population based epidemiological studies in Myasthenia Gravis
2010 Standout
Immunotherapy in autoimmune neuromuscular disorders
2002
Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia
1997
Seronegative Myasthenia Gravis: Evidence for Plasma Factor(s) Interfering with Acetylcholine Receptor Functiona
1993
Cellular and Synaptic Mechanisms of Anti-NMDA Receptor Encephalitis
2010 Standout
Autoimmune Channelopathies and Related Neurological Disorders
2006
Autoimmune Disorders of Neuronal Potassium Channels
2003
Proteins that interact with the pore-forming subunits of voltage-gated ion channels
1995
Potassium channel antibody‐associated encephalopathy: a potentially immunotherapy‐responsive form of limbic encephalitis
2004 Standout
Acquired neuromyotonia: Evidence for autoantibodies directed against K+channels of peripheral nerves
1995
Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia
2010 Standout
Myasthenia gravis
2019 Standout
Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series
2010 Standout
Antiamphiphysin Antibodies Are Associated With Various Paraneoplastic Neurological Syndromes and Tumors
1999
Synaptic vesicle proteins in exocytosis: what do we know?
1993 StandoutNobel
N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes
2010 Standout
Autoimmune channelopathies: John Newsom-Davis's work and legacy
2008
Clinical and serological study of myasthenia gravis in HuBei Province, China
2006
Lambert–Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies
2011
Lambert‐Eaton Myasthenic Syndrome
2003
Advances in the Diagnosis of Neuromuscular Junction Disorders
2005
Treatment in Lambert–Eaton myasthenic syndrome
2012
Management of paraneoplastic neurological syndromes: report of an EFNS Task Force
2006
The European LEMS Registry: Baseline Demographics and Treatment Approaches
2015
Guidelines for treatment of autoimmune neuromuscular transmission disorders
2010
Low specificity of voltage-gated calcium channel antibodies in Lambert–Eaton myasthenic syndrome: a call for caution
2018
HLA and smoking in prediction and prognosis of small cell lung cancer in autoimmune Lambert–Eaton myasthenic syndrome
2004
Antibodies to voltage-gated potassium and calcium channels in epilepsy
2006
Calcium-Channel Antibodies in the Lambert–Eaton Syndrome and Other Paraneoplastic Syndromes
1995
Polymyositis and dermatomyositis
2003 Standout
Autoimmunity to SOX2, clinical phenotype and survival in patients with small-cell lung cancer
2010
Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis
2010 Standout
Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis
2010 Standout
Amyotrophic Lateral Sclerosis
2001 Standout
Paraneoplastic syndromes of the spinal cord, nerve, and muscle
2000
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
2004 Standout
An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System
2005 Standout
Antibodies and neuronal autoimmune disorders of the CNS
2009
Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients
2000 Standout
Paraneoplastic disorders of the central and peripheral nervous systems
2013
Myasthenia gravis: subgroup classification and therapeutic strategies
2015 Standout
Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System
2017
Phosphorylation of synaptotagmin I by casein kinase II.
1993 StandoutNobel
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Pathogenic immune mechanisms at the neuromuscular synapse: the role of specific antibody‐binding epitopes in myasthenia gravis
2013
Antibody-Mediated Encephalitis
2018 Standout
IgG from ?seronegative? myasthenia gravis patients binds to a muscle cell line, TE671, but not to human acetylcholine receptor
2000
P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer
2002
The Three Es of Cancer Immunoediting
2004 Standout
Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain.
1996
Treatment for Lambert-Eaton myasthenic syndrome
2011
A Treatment Algorithm for Lambert‐Eaton Myasthenic Syndrome
1998
Molecular Machinery Mediating Vesicle Budding, Docking and Fusion.
1996 StandoutNobel
The inflammatory reaction of paraneoplastic ganglionitis and encephalitis: an immunohistochemical study
1993
Autoantibody-Mediated Channelopathies at the Neuromuscular Junction
1997
Evidence for synaptotagmin as an inhibitory clamp on synaptic vesicle release in Aplysia neurons.
1995 StandoutNobel
The synaptic vesicle protein synaptotagmin associates with calcium channels and is a putative Lambert-Eaton myasthenic syndrome antigen.
1992
Binding of the synaptic vesicle v-SNARE, synaptotagmin, to the plasma membrane t-SNARE, SNAP-25, can explain docked vesicles at neurotoxin-treated synapses
1997 StandoutNobel
Immunobiology of Dendritic Cells
2000 Standout
Amyotrophic lateral sclerosis and antibodies to voltage‐gated calcium channels—new doubts
1996
Interactive cloning with the SH3 domain of N-src identifies a new brain specific ion channel protein, with homology to Eag and cyclic nucleotide-gated channels
1997 StandoutNobel
Serum antibodies in epilepsy and seizure-associated disorders
2005
Seronegative myasthenia gravis
1997
Promotion of direct reprogramming by transformation-deficient Myc
2010 StandoutNobel
Works of I Johnston being referenced
Incidence of serum anti-P/Q-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome
1997
Autoantibody Specificities in Lambert‐Eaton Myasthenic Syndrome
1993
Cross-linking of presynaptic calcium channels: a mechanism of action for Lambert-Eaton myasthenic syndrome antibodies at the mouse neuromuscular junction
1993
Heterogeneity of calcium channel autoantibodies detected using a small‐cell lung cancer line derived from a Lambert‐Eaton myasthenic syndrome patient
1994
Calcium channel autoantibodies in the lambert‐eaton myasthenic syndrome
1991
An improved diagnostic assay for Lambert-Eaton myasthenic syndrome.
1995
Seronegative myasthenia gravis: A plasma factor inhibiting agonist‐induced acetylcholine receptor function copurifies with IgM
1991